Extrafine HFA-beclomethasone-formoterol vs. nonextrafine combination of an inhaled corticosteroid and a long acting β2-agonist in patients with persistent asthma: A systematic review and meta-analysis.

Extrafine HFA-beclomethasone-formoterol vs. nonextrafine combination of an inhaled corticosteroid and a long acting β2-agonist in patients with persistent asthma: A systematic review and meta-analysis.

<h4>Objective</h4>Airway inflammation in asthma involves not only the central airways but extends to peripheral airways. Lung deposition may be key for an appropriate treatment of asthma. We compared the clinical effects of extrafine hydrofluoroalkane (HFA)-beclomethasone-formoterol (BDP...

Full description

Bibliographic Details
Main Authors:	Ting Liu, Dan Yang, Chuntao Liu
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2021-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0257075

Similar Items

Small Airways, Big Problem: Extrafine beclomethasone/formoterol in asthma and chronic obstructive pulmonary disease
by: Ashfaq Hasan, et al.
Published: (2021-01-01)

Extrafine combination beclomethasone dipropionate/ formoterol therapy in obstructive lung diseases
by: I. N. Trofimenko, et al.
Published: (2020-08-01)

Rapid effects of extrafine beclomethasone dipropionate/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trial
by: O'Connor Brian J, et al.
Published: (2011-12-01)

COMPARATIVE EFFICACY OF INHALED DRUGS FORMOTEROL / BECLOMETHASONE AND FORMOTEROL / BUDESONIDE AND BRONCHIAL ASTHMA
by: V. A. Nikitin, et al.
Published: (2016-03-01)

Penggunaan Extrafine Beclometason Diproprionat/Formoterol Fumarat pada PPOK [Combined Extrafine Beclomethason Diproprionat/Formoteral Fumarat in COPD]
by: Sakinatus Syarifah, et al.
Published: (2019-05-01)

Extrafine inhaled corticosteroid therapy in the control of asthma
by: Ivancs&oacute; I, et al.
Published: (2013-06-01)

Equivalence of hydrofluoroalkane (HFA) and chlorofluorocarbons (CFC) formulations of inhaled beclomethasone.
by: Lipworth, B, et al.
Published: (2000)

Predictors of clinical response to extrafine and non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma
by: Fajri Gafar, et al.
Published: (2018-12-01)

Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD
by: Scichilone N, et al.
Published: (2014-11-01)

Comparison of Dry-Powder Inhaler and Pressurized Metered-Dose Inhaler Formulations of Extrafine Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium in Patients with COPD: The TRI-D Randomized Controlled Trial
by: Beeh KM, et al.
Published: (2021-01-01)

Safety of hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol.
by: Thompson, P, et al.
Published: (1998)

Inhaled Beclomethasone with or whiteout Montelukast in the Management of Pediatric Persistent Asthma
by: I Mohammadzadeh, et al.
Published: (2018-07-01)

Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD
by: Paolo Montuschi, et al.
Published: (2018-04-01)

Comparison of efficacy between long-acting beta 2-agonists (formoterol fumarate) and leukotriene-receptor antagonists (montelukast) as add-on therapy to inhaled corticosteroids (budesonide) in moderate persistent asthma
by: Sasikala Kumaravel, et al.
Published: (2014-01-01)

Inhaled beclomethasone/formoterol in idiopathic pulmonary fibrosis: a randomised controlled exploratory study
by: Caroline E. Wright, et al.
Published: (2017-12-01)

Pharmacokinetics of extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide in adolescent and adult patients with asthma
by: Piotr Kuna, et al.
Published: (2022-08-01)

The efficacy of extrafine beclomethasone dipropionate–formoterol fumarate in COPD patients who are not "frequent exacerbators": a post hoc analysis of the FORWARD study
by: Singh D, et al.
Published: (2017-11-01)

Effects of inhaled beclomethasone dipropionate/formoterol fumarate/glycopyrronium on diaphragmatic workload and lung function in uncontrolled asthma: a case report
by: Antonio Maiorano, et al.
Published: (2024-03-01)

Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events
by: Christopher J Cates, et al.

Asthma control in patients receiving inhaled corticosteroid and long-acting beta<sub>2</sub>-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation
by: Nicolini Gabriele, et al.
Published: (2011-07-01)

Inhaled beclomethasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma (Respir Med 1999; 93: 245-251)
by: Pavord, I
Published: (2000)

Determinants of response to inhaled extrafine triple therapy in asthma: analyses of TRIMARAN and TRIGGER
by: Dave Singh, et al.
Published: (2020-10-01)

Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β-adrenoceptor agonist, with formoterol in patients with asthma
by: Leif Bjermer, et al.
Published: (2013-10-01)

A safety evaluation of an extrafine aerosol of beclomethasone dipropionate in 6161 patients using the UK SAMM guidelines
by: Ayres, J, et al.
Published: (2002)

Cough and asthma: the role of inhaled corticosteroids and ß2-agonists
by: Mario Cazzola, et al.
Published: (2008-02-01)

An assessment of asthma exacerbations in pediatric patients using a long-acting B2-agonist plus inhaled corticosteroid versus an inhaled corticosteroid alone
by: Yousif S. Alakeel, et al.
Published: (2022-03-01)

Impact of adherence to treatment with inhaled corticosteroids/long-acting β-agonists on asthma outcomes in the United States
by: Carlyne M. Averell, et al.
Published: (2022-08-01)

Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review
by: Halpin David MG, et al.
Published: (2006-06-01)

Estimating Inhaled Corticosteroid Exposure from Short-Acting β2-Agonist–Inhaled Corticosteroid Rescue
by: Lugogo N, et al.
Published: (2023-05-01)

The effect of fine-particle size and extrafine particle size inhaled corticosteroid in reducing airway resistance in asthmatic patients
by: Mohamed Faisal Abdul Hamid, et al.
Published: (2023-03-01)

Management of severe COPD exacerbations: focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide
by: Mantero M, et al.
Published: (2018-07-01)

Comparing the clinical efficacy and safety of high doses of beclomethasone inhaler with medium doses of beclomethasone inhaler combined with oral aminophylline or montelukast tablets in persistent asthmatic Iraqi patients.
by: Ali L. Jassim, et al.
Published: (2011-06-01)

The effect of inhaled extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide on distal and central airway indices, assessed using Functional Respiratory Imaging in COPD (DARWiIN)
by: Gwen S. Skloot, et al.
Published: (2023-10-01)

Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways
by: Luigino Calzetta, et al.
Published: (2018-04-01)

The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
by: Mohsen Sadatsafavi, et al.
Published: (2021-10-01)

Montelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthma
by: Scaparrotta Alessandra, et al.
Published: (2012-07-01)

Inhaled corticosteroids and leukotriene modifiers as mono-therapy for mild persistent asthma
by: Amr Radwan, et al.
Published: (2013-07-01)

Reduction in asthma deteriorations in subjects with persistent asthma uncontrolled on low-, medium-, or high-dose inhaled corticosteroids: a pooled analysis from three clinical trials using combined mometasone furoate/formoterol
by: Weinstein SF, et al.
Published: (2011-11-01)

Assessment of Symptoms Control, Pulmonary Function and Related Quality of Life in Asthmatic Patients Treated with Extrafine Beclomethasone Dipropionate/Formoterol Fumarate 100/6 μg pMDI: Results of a Multicenter Observational Study in Romania (ALFRESCO Study)
by: Ulmeanu R, et al.
Published: (2022-07-01)

Impulse Oscillometry; Therapeutic Impacts of Transdermal Long-Acting Beta-2 Agonist Patch in Elderly Asthma with Inhaled Corticosteroid Alone
by: Hiroshi Tanaka, et al.
Published: (2012-01-01)